Get the Stockscreener App
6.51
6.60%
-0.46
Pre-market:
6.02
-0.49
-7.53%
Acrivon Therapeutics Inc Stock (ACRV) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
16.08%
17.67
|
21.05 | 16.14 | 15.52 | 14.39 |
| Operating Income/Loss |
16.08%
-17.67
|
-21.05 | -16.14 | -15.52 | -14.39 |
| Nonoperating Income/Loss |
1.182
|
- | 1.671 | 1.606 | 1.637 |
| Income/Loss From Continuing Operations Before Tax |
14.37%
-16.49
|
-19.25 | -14.47 | -13.91 | -12.76 |
| Income/Loss From Continuing Operations After Tax |
14.37%
-16.49
|
-19.25 | -14.47 | -13.91 | -12.76 |
|
Net Income/Loss
|
14.37%
-16.49
|
-19.25 | -14.47 | -13.91 | -12.76 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
25,962%
22.59
|
0.0867 | 22.08 | 21.97 | 21.92 |
| Diluted Average Shares |
25,962%
22.59
|
0.0867 | 22.08 | 21.97 | 21.92 |
| Basic Earnings Per Share |
16.09%
-0.73
|
-0.87 | -0.66 | -0.63 | -0.58 |
| Diluted Earnings Per Share |
16.09%
-0.73
|
-0.87 | -0.66 | -0.63 | -0.58 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):